TGTX icon

TG Therapeutics
TGTX

Overview Fund Activity

175 hedge funds and large institutions have $1.63B invested in TG Therapeutics in 2020 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 66 increasing their positions, 38 reducing their positions, and 23 closing their positions.

Holders
175
Holders Change
+29
Holders Change %
+19.86%
% of All Funds
3.6%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.1%
New
53
Increased
66
Reduced
38
Closed
23
Calls
$41.9M
Puts
$23.4M
Net Calls
+$18.5M
Net Calls Change
-$13.6M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$246M
2
RCM
2
RA Capital Management
Massachusetts
$249M
3
State Street
3
State Street
Massachusetts
$97.9M
4
FCM
4
Farallon Capital Management
California
$29.2M
5
EAM
5
Eagle Asset Management
Florida
$26.8M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$9.81M
2
MP
2
Mangrove Partners
Connecticut
$13.4M
3
ACA
3
Avoro Capital Advisors
New York
$0
4
AC
4
Armistice Capital
New York
$0
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$8.36M
Name Market Value Shares Shares
Change 		Shares
Change %
PCM
201
Prelude Capital Management
New York
– – – –
PA
202
Parallel Advisors
California
$0 45 +45 New
5 6 7 8
9